Natco Pharma Limited or NATCOPHARM

V C Nannapaneni was promoting Natco Pharma in 1981 as a private company. It functions in the business of research, developing, manufacturing, and marketing of pharmaceutical substances and finished dosage forms for both Indian as well as international markets. The company also began its operations in 1984 in Andhra Pradesh. During the first year of its operations, it achieved a sales figure of around Rs 0.5 million. The company’s first product was Cardicap, which is an anti-anginal drug. And since then, the company has introduced several dosage forms into the market. And by 1985, it had dosage forms in the cardiovascular, anti-cold, anti-asthmatic and antibiotic sections. The company was soon ranked 82nd in the sales among Indian pharmaceutical companies in the year 1994. Natco is also one of the largest contract manufacturers in India. Some of the well–known companies such as Ranbaxy, Dr. Reddy's Laboratories, John Wyeth, etc. get their products manufactured by Natco. Natco Pharma grew in size when three companies, Natco Parenterals, Dr. Karanth Pharma Labs and Natco Laboratories merged with it. Today the company, which began its operations as a single unit with 20 employees, has four manufacturing facilities and employs around 1500 people. It has online data for analysis and decision making. Consistently ranked among the fastest-growing pharmaceutical companies in the country, Natco is utilizing its collective experience to kick start its further plans as a global company.

The business area of the company

Natco manufactures a comprehensive range of branded and generic dosage forms, bulk actives and intermediates for both Indian as well as international markets. The product range of the company includes:

Diltiazem
Omeprazole
Lansoprazole
Isosorbides
Sumatriptan succinate
Ondansetron
Sertra

NATCOPHARM Share Price Chart: Live